1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics in North America Countries, October 2016 (p7)

Biopharmaceutical Analysis & Statistics in North America Countries, October 2016 (p7)

181-210 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H2 2016

CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Biological Therapy, Cancer, Pathology, Oncology
  • Countries : United States
Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2016

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Telomerase ...

  • Industries : Therapy, Cancer, Pathology, Pharmaceutical
  • Countries : United States, World
T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H2 2016

T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘T Cell Surface Glycoprotein CD3 Epsilon ...

  • Industries : Therapy, Oncology, Chronic Disease, Pathology
  • Countries : World, United States, Europe
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H2 2016

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Histone Deacetylase 6 (Protein Phosphatase 1 ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Ulcerative Colitis - Pipeline Review, H2 2016

Ulcerative Colitis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Ulcerative Colitis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis - Pipeline Review, H2 2016, provides an overview ...

  • Industries : Pathology, Healthcare, Therapy
  • Countries : United States
B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • October 2016
  • by Global Markets Direct

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016, ...

  • Industries : Cancer, Pathology, Biotechnology, Biological Therapy
  • Countries : United States
Febrile Neutropenia - Pipeline Review, H2 2016

Febrile Neutropenia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Febrile Neutropenia - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Febrile Neutropenia - Pipeline Review, H2 2016, provides an overview ...

  • Industries : Therapy, Biopharmaceutical
  • Countries : United States, World
Post Menopausal Osteoporosis - Pipeline Review, H2 2016

Post Menopausal Osteoporosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Post Menopausal Osteoporosis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis - Pipeline Review, H2 2016, ...

  • Industries : Chronic Disease, Pathology, Therapy, Pharmaceutical
  • Countries : United States, World
Osteoporosis - Pipeline Review, H2 2016

Osteoporosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Osteoporosis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoporosis - Pipeline Review, H2 2016, provides an overview of the ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, World
Head And Neck Cancer - Pipeline Review, H2 2016

Head And Neck Cancer - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • October 2016
  • by Global Markets Direct

Head And Neck Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer - Pipeline Review, H2 2016, provides an ...

  • Industries : Healthcare, General Medicine and Specialty Medicine
  • Countries : United States
Gastric Cancer - Pipeline Review, H2 2016

Gastric Cancer - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Gastric Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer - Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Cancer, Pathology
  • Countries : United States
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review, H2 2016

Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Placenta Growth Factor (Vascular Endothelial Growth Facto ...

  • Industries : Pathology, Biopharmaceutical, Therapy
  • Countries : United States
Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Pipeline Review, H2 2016

Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL ...

  • Industries : Biopharmaceutical, Therapy, Pathology, Cancer
  • Countries : United States, World
Asthma - Pipeline Review, H2 2016

Asthma - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • October 2016
  • by Global Markets Direct

Asthma - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Pipeline Review, H2 2016, provides an overview of the Asthma (Respiratory) ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States
Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) - Pipeline Review, H2 2016

Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Superoxide Dismutase ...

  • Industries : Pathology, Mental Health, Therapy, Pharmaceutical
  • Countries : United States, World
Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2016

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glycogen Synthase Kinase ...

  • Industries : Chronic Disease, Pathology, Biopharmaceutical, Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World, United States, Asia
Ubiquitin Enzymes: Key Targets and Future Market Potential, 2016-2030

Ubiquitin Enzymes: Key Targets and Future Market Potential, 2016-2030

  • $ 2349
  • Industry report
  • October 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION The ubiquitin proteasome system (UPS) is one of the key protein degradation pathway involved in the control of protein homeostasis and turnover that mediates the regulation of several cellula ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States
Omega Protein Corporation : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis

Omega Protein Corporation : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis

  • $ 125
  • Company report
  • October 2016
  • by GlobalData

Summary Canadean's "Omega Protein Corporation : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States
Burcon NutraScience Corporation : Ingredients - Company Profile, SWOT and Financial Analysis

Burcon NutraScience Corporation : Ingredients - Company Profile, SWOT and Financial Analysis

  • $ 125
  • Company report
  • October 2016
  • by GlobalData

Summary Canadean's "Burcon NutraScience Corporation : Ingredients - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile ...

  • Countries : United States
Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2016

Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, World
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cytotoxic T Lymphocyte Protein 4 (Cytotoxic ...

  • Industries : Therapy, Oncology, Cancer
  • Countries : United States
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2016

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin ...

  • Industries : Therapy, Pharmaceutical, Biopharmaceutical, Pathology
  • Countries : World, Europe, United States
Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2016

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) ...

  • Industries : Mental Health, Therapy, Biopharmaceutical, Pathology, Pharmaceutical
  • Countries : United States, World
Gastroenteritis - Pipeline Review, H2 2016

Gastroenteritis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Gastroenteritis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastroenteritis - Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Pathology
  • Countries : United States
Hepatitis D - Pipeline Review, H2 2016

Hepatitis D - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Hepatitis D - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis D - Pipeline Review, H2 2016, provides an overview of the Hepatitis ...

  • Industries : Pathology
  • Countries : United States, World
Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2016

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline ...

  • Industries : Pathology, Cancer
  • Countries : World, Spain, United States
Glycoprotein 41 (gp41) - Pipeline Review, H2 2016

Glycoprotein 41 (gp41) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Glycoprotein 41 (gp41) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glycoprotein 41 (gp41) - Pipeline Review, H2 2016’, provides in depth analysis on Glycoprotein 41 (gp41) targeted ...

  • Industries : Pathology
  • Countries : United States
Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by GlobalData

Summary Provectus Biopharmaceuticals, Inc. (Provectus), formerly Provectus pharmaceuticals, Inc. is a biopharmaceutical company that develops pharmaceuticals for oncology and dermatology indications. The ...

  • Industries : Biopharmaceutical
  • Countries : United States
Humira Biosimilars Clinical Trial Insight

Humira Biosimilars Clinical Trial Insight

  • $ 1500
  • Industry report
  • October 2016
  • by PNS Pharma

“Humira Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 33 biosimilars version of Humira drug in clinical pipeline. More than 10 of these biosimilars ...

  • Industries : Therapy, Biopharmaceutical, Oncology
  • Countries : United States

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.